Search within Resources
555 results found
One size does not fit all: adapt and localise for effective, proportionate and equitable responses to COVID-19 in Africa
A critical part of adaptation and proportionality is a localisation of response that builds on people’s own inventiveness and the knowledge and experience of local organisations.
This analysis highlights the drivers and evidence of the negative impact of 'vertical’ responses focused primarily on preventing and containing COVID-19
This review draws on multiple secondary data sources to inform RCCE strategies and policies and provides examples of successful practice
A review of 46 published reports of Ebola-related activities undertaken during the 2013–2016 outbreak in Guinea
Key considerations for COVID-19 response and recovery in indigenous populations, with a particular focus on the Amazon region of South America
Best data practice recommendations for the use of technology for surveillance, fact-checking and coordinated control during crisis or emergency response.
Key considerations about the social, political and economic context shaping the outbreak of Ebola in the N’Zérékoré prefecture, Guinea.
At the time of writing there have been 18 cases, 9 deaths and 6 recoveries.
The current Ebola outbreak in West Africa is by far the largest ever recorded, and already numbers more cases than all past Ebola epidemics combined. This Briefing outlines the overall impact on health.
The lack of a prompt, robust, and efficient response to Ebola from the international community contributes to lack of trust in governments and exacerbates social tensions, increasing the possibility of profound unrest in these fragile countries.
A multidimensional and multi-sector approach is required to contain the outbreak of Ebola while safeguarding against a long-term food security crisis.
Fear of contracting EVD and mistrust of the health system has made people reluctant to seek treatment from health facilities, further impacting the health sector and increasing the risk of mortality and morbidity from otherwise treatable diseases.